Updated from 7:10 a.m. EST
rose in Friday's premarket session after Merrill Lynch reiterated a bullish call that dates back to January. The brokerage, which rates the stock a buy, thinks competitive advantages over rival
will materialize in the stock price during 2005's second half, driven by subscriber growth. The stock is up 8 cents to $5.53.
said Thursday that it expects earnings to be at the high end of its forecast of 75 cents to 80 cents a share for the year ending this month. Analysts were looking for 71 cents per share for 2005, according to Thomson First Call. The drug company said the forecast does not include costs related to the termination of its planned
earned $27.6 million, or 47 cents a share, in the fourth quarter ended Jan. 29. Excluding one-time items, the company earned 55 cents a share, in line with Wall Street estimates, according to Thomson First Call. Same-store sales rose 5.1% in the quarter, while overall sales were $492.3 million. Strong holiday sales in December fueled the rise in quarterly earnings. Looking ahead, the company expects to earn 33 cents or 34 cents per share in the first quarter. According to Thomson First Call, analysts are looking for 33 cents per share.
reported net income on Thursday of $122.8 million, or $1.62 a share, for the fourth quarter ended Jan. 23. According to Thomson First Call, analysts were expecting earnings of $1.61 a share. Fourth-quarter sales rose 4.3% from a year ago to $1.37 billion. The higher quarterly profit was helped by the Borders domestic and international segments. Looking ahead, the company expects first-quarter earnings to come in at breakeven to 2 cents a share. Analysts were expecting EPS of a penny, according to Thomson First Call.
announced Thursday that it received a $15 million contract from the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health, to produce three botulinum neurotoxin monoclonal antibodies designed to counteract biological agents.
reported earnings of $17.4 million, or 13 cents a share, for the fourth quarter ended Dec. 31. The profit excluded a tax benefit and debt prepayment charges. On that basis, analysts were expecting earnings of 12 cents a share, according to Thomson First Call. Revenue increased 60.5% from last year to $24.4 million. Looking ahead, the company expects to earn between 6 cents and 8 cents a share on revenue of $23.4 to $23.7 million for the first quarter. Analyst estimates are 10 cents a share and revenues of $24.2 million.